CASP3 and renal fibrosis: Similarly, mice that received subcapsular miR-423-5p injection at the time of renal IRI showed reduced caspase-3 activation within PTCs, reduced microvascular congestion, decreased microvascular rarefaction, and lower levels of renal fibrosis.